Results 41 to 50 of about 11,489 (193)

Tuberculosis vaccine: pipeline approaches and future prospective [PDF]

open access: yes, 2011
Tuberculosis (TB), despite anti-mycobacterial therapies and vaccine, is a deadly infectious disease with about 12 million incident cases worldwide. Existing Bacillus Calmette-Guérin (BCG) vaccine is unquestionably inexpensive, safe and effective ...
Ankita Singh   +2 more
core   +2 more sources

Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus [PDF]

open access: yesJournal of Virology, 2005
ABSTRACT The use of classical smallpox vaccines based on vaccinia virus (VV) is associated with severe complications in both naïve and immune individuals. Modified vaccinia virus Ankara (MVA), a highly attenuated replication-deficient strain of VV, has been proven to be safe in humans and immunocompromised animals, and its efficacy against ...
Stittelaar, KJ   +11 more
openaire   +5 more sources

Vaccinia protein C16 blocks innate immune sensing of DNA by binding the Ku complex [PDF]

open access: yes, 2011
VACV gene C16L encodes a 37-kDa protein that is highly conserved in orthopoxviruses and functions as an immunomodulator. Intranasal infection of mice with a virus lacking C16L (vΔC16) induced less weight loss, fewer signs of illness and increased ...
Peters, Nicholas Edward   +1 more
core   +1 more source

Macaque models of human infectious disease. [PDF]

open access: yes, 2008
Macaques have served as models for more than 70 human infectious diseases of diverse etiologies, including a multitude of agents-bacteria, viruses, fungi, parasites, prions.
Abe   +330 more
core   +1 more source

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara

open access: yesExpert Review of Vaccines, 2009
Recombinant modified vaccinia virus Ankara (MVA) is attractive and promising as a novel viral vector for the expression of foreign genes of interest because it possesses unique properties. In particular, its excellent safety profile and the availability of versatile vector technologies have frequently made MVA the vaccinia virus of choice for ...
Guus F. Rimmelzwaan, Gerd Sutter
openaire   +3 more sources

Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses [PDF]

open access: yes, 2014
Due to the essential role macrophages play in antiviral immunity, it is important to understand the intracellular and molecular processes that occur in macrophages following infection with various strains of vaccinia virus, particularly those used as ...
Guerra, Susana M.   +5 more
core   +2 more sources

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara [PDF]

open access: yesBioTechniques, 2000
Recombinant vaccinia viruses are extremely valuable tools for research in molecular biology and immunology. The extension of vaccinia vector technology to replication-deficient and safety-tested virus strains such as modified vaccinia virus Ankara (MVA) have made this versatile eukaryotic expression system even more attractive for basic and clinical ...
Staib, C.   +5 more
openaire   +5 more sources

Modified Vaccinia Virus Ankara-Based Vaccine Vectors Induce Apoptosis in Dendritic Cells Draining from the Skin via both the Extrinsic and Intrinsic Caspase Pathways, Preventing Efficient Antigen Presentation [PDF]

open access: yes, 2012
Dendritic cells (DC) are potent antigen-presenting cells and central to the induction of immune responses following infection or vaccination. The collection of DC migrating from peripheral tissues by cannulation of the afferent lymphatic vessels provides
Charleston, B.   +6 more
core   +1 more source

Modified vaccinia virus Ankara as a vaccine against feline coronavirus: Immunogenicity and efficacy [PDF]

open access: yesJournal of Feline Medicine and Surgery, 2004
Feline infectious peritonitis virus (FIPV) is a coronavirus that induces a fatal systemic disease mediated by an inappropriate immune response. Most previous vaccination attempts against FIPV were unsuccessful because IgG antibodies against the surface protein enhance the infection.
Joelle Cronier   +4 more
openaire   +3 more sources

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells in Vitro, Ex Vivo and in Vivo [PDF]

open access: yes, 2017
Modified Vaccinia virus Ankara (MVA) is a promising vaccine vector with an excellent safety profile. However, despite extensive pre-clinical and clinical testing, surprisingly little is known about the cellular tropism of MVA, especially in relevant ...
Altenburg, A.F. (Arwen)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy